ArticleMedicine2020

Effect and safety of Chinese patent medicine capsules for recurrent angina pectoris after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.

Yize Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.